| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TAX PREP FEES | 675 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 186 SHR GSK PLC | 2020-04 | PURCHASE | 2024-08 | 7,511 | 7,701 | -190 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| MERRILL LYNCH EQUITIES | 151,233 | 151,233 |
| MERRILL LYNCH MUTUAL FUNDS | 98,534 | 98,534 |
| Description | Amount |
|---|---|
| PRIOR YEAR FEDERAL TAX DUE | 134 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| INVESTMENT FEES | 2,456 | |||
| NJ STATE FILING FEE | 31 | |||
| BANK FEES | 11 |
| Description | Amount |
|---|---|
| CHANGE IN UNREALIZED GAIN | 18,451 |